The era of omics in Endocrinology: Great opportunity for the advancement of knowledge in the pathological pathways of endocrine diseases
PDF (Español (España))

Keywords

Data Analysis
Endocrine System Diseases
Risk Factors
thyroid diseases
Thyroid Neoplasms
Precision Medicine
Genomics

How to Cite

Jimenez-Canizales, C. E. ., Parra-Medina, R. ., & Payán-Gómez, C. . (2024). The era of omics in Endocrinology: Great opportunity for the advancement of knowledge in the pathological pathways of endocrine diseases. Revista Colombiana De Endocrinología, Diabetes &Amp; Metabolismo, 11(1). https://doi.org/10.53853/encr.11.1.840

Abstract

The omics sciences are scientific disciplines that allow the large-scale study of biological molecules such as genes, proteins and metabolites, and these disciplines include genomics, proteomics and metabolomics, among others. The analysis of data obtained through omics sciences can lead to a better understanding of the biological mechanisms underlying different diseases, better classification of diseases and the identification of new therapeutic targets. The use of omics sciences has the potential to revolutionize clinical Endocrinology and have contributed significantly to improve the understanding of how genetic and metabolic alterations are involved in the development and evolution of various endocrinopathies.

Thyroid pathologies are some of the endocrine diseases in which the use of omic sciences has advanced the understanding of the underlying mechanisms, their classification and prognosis; within these, hypothyroidism and thyroid nodules are among the most frequent diseases, where their epidemiology is variable depending on age, ethnicity, environmental risk factors and geographic location, in addition, these pathologies are usually more frequent in women.

https://doi.org/10.53853/encr.11.1.840
PDF (Español (España))

References

Karczewski KJ, Snyder MP. Integrative omics for health and disease. Nature Rev Genet. 2018;19:299-310. https://doi.org/10.1038/nrg.2018.4

Stratakis CA. Genomics and precision medicine and their impact on endocrinology. Endocr Connect. 2023;12(7):e230106. https://doi.org/10.1530/EC-23-0106

Piga I, L'Imperio V, Capitoli G, Denti V, Smith A, Magni F, et al. Paving the path toward multi-omics approaches in the diagnostic challenges faced in thyroid pathology. Expert Rev Proteomics. 2023;20(12):419-37. https://doi.org/10.1080/14789450.2023.2288222

Vargas-Uricoechea H, Builes-Barrera C, Arenas-Quintero H, Castellanos-Pinedo A, Restrepo-Erazo K, Duque-Ossman JJ, et al. Colombian consensus for the diagnosis, treatment and follow-up of hypothyroidism in the adult population. Rev Colomb Endocrinol Diabet Metab. 2023;10(4). https://doi.org/10.53853/encr.10.4.818

Alzahrani AS. Clinical use of molecular data in thyroid nodules and cancer. J Clin Endocrinol Metab. 2023;108(11):2759-71. https://doi.org/10.1210/clinem/dgad282

Durante C, Grani G, Lamartina L, Filetti S, Mandel SJ, Cooper DS. The diagnosis and management of thyroid nodules: a review. JAMA. 2018;319(9):914-24. https://doi.org/10.1001/jama.2018.0898

de Oliveira Andrade LJ, Matos de Oliveira L, Vinhaes Bittencourt AM, Matos de Oliveira LC, Matos de Oliveira GC. Utilizando enfoques de bioinformática para realizar un análisis comparativo del transcriptoma de la tiroides en trastornos tiroideos. Rev Colomb Endocrinol Diabet Metab. 2024;11(1). https://doi.org/10.53853/encr.11.1.847

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright (c) 2024 Revista Colombiana de Endocrinología, Diabetes & Metabolismo

Dimensions


PlumX


Downloads

Download data is not yet available.